NONSQUAMOUS NON SMALL CELL LUNG CANCER
Clinical trials for NONSQUAMOUS NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSQUAMOUS NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSQUAMOUS NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of immune drugs shows promise in lung cancer trial
Disease control CompletedThis phase 2 study tested three different drug combinations in 151 people with advanced non-small cell lung cancer that had not been treated before. The drugs help the immune system attack cancer cells. Researchers measured how many patients' tumors shrank or stopped growing, and…
Matched conditions: NONSQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cocktail of drugs shows promise for tough lung cancer
Disease control CompletedThis phase 3 trial tested whether adding the targeted therapy lenvatinib to a standard combination of immunotherapy (pembrolizumab) and chemotherapy could help people with a common type of advanced lung cancer live longer. The study enrolled 761 adults with metastatic nonsquamous…
Matched conditions: NONSQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cocktail aims to stall lung cancer progression
Disease control CompletedThis Phase 3 trial tested whether adding the targeted drug lenvatinib to standard chemotherapy plus the immunotherapy pembrolizumab helps people with advanced nonsquamous non-small cell lung cancer live longer without their cancer growing. The study enrolled 201 adults in China w…
Matched conditions: NONSQUAMOUS NON SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 26, 2026 14:55 UTC